Sharad Joshi is a Senior Advisor to Onstott Group and the CEO of Satio Inc., a biotechnology company transforming blood collection, diagnostics, and drug delivery through proprietary patch technology. With over 30 years of experience in the medical devices industry, he has led global product innovation, strategic expansion, and high-growth ventures across healthcare markets. Sharad has held leadership roles at multiple life sciences companies, including CEO of NanoDx Inc., and currently serves as a non-executive director at Oventus Medical. He brings deep expertise in scaling mission-driven businesses that improve patient outcomes worldwide.